Toronto - Delayed Quote ? CAD Aurora Cannabis Inc. (ACB.TO) Follow Compare 8.43 +0.79 (+10.34%) At close: 4:00 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch ACB and MedReleaf Australia launch premium medical cannabis oils, offering tailored cannabinoid formulations for patient care. Zacks ? 5 days ago ACB +10.71% DGX ADUS Aurora Introduces Innovative Cannabis Oil Range to Meet Diverse Patient Needs in Australia Aurora Cannabis Inc., (NASDAQ: ACB) (TSX: ACB) – the Canadian based global leader in medical cannabis, in conjunction with MedReleaf Australia, is pleased to announce an enhanced product range of premium medical cannabis oil in Australia. This expansion reinforces Aurora's dedication to providing high-quality, innovative cannabis solutions to patients around the world. Now available for physicians to prescribe, the new cannabis oils include a variety of cannabinoid ratios to suit diverse patient PR Newswire ? 6 days ago ACB +10.71% Is It Time to Load Up on Aurora Cannabis Stock? This Canadian pot stock has defied the broader downturn among its peer group in 2024. Motley Fool ? 13 days ago ACB +10.71% ACB Stock Likely to Gain From Genome BC-Funded Aroma Research Project Aurora Cannabis' new collaboration on the Genome BC-Funded Project addresses distinct cannabis aromas. Zacks ? 19 days ago ACB +10.71% BSX Aurora Cannabis Down Slightly in U.S. Pre-Market After Reporting Project Collaboration Focused on Distinct Cannabis Aromas Aurora Cannabis Down Slightly in U.S. Pre-Market After Reporting Project Collaboration Focused on Distinct Cannabis Aromas PREMIUM MT Newswires ? 20 days ago ACB +10.71% Aurora Cannabis Announces Collaboration on Genome BC-Funded Project Addressing Distinct Cannabis Aromas Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) –—the Canadian based leading global medical cannabis company, today announced a research grant provided to the University of British Columbia (UBC) by Genome British Columbia (Genome BC), a not-for-profit organization supporting world-class genomics research and innovation in British Columbia. The project, Genomics-enabled Aroma Breeding in Cannabis, will directly support Aurora's genetics work the project, is led by Drs. Jose Celedon, Principal Scie PR Newswire ? 20 days ago ACB +10.71% Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced the appointments of CEO Miguel Martin to the additional role of Executive Chairman and outgoing Chairman Ron Funk as Lead Independent Director. Both appointments follow unanimous votes by Aurora's Board and are effective immediately. CNW Group ? last month ACB +10.71% Update: Aurora Cannabis Rises 3% as Advances "Groundbreaking" Research in Auto-Flowering Update: Aurora Cannabis Rises 3% as Advances "Groundbreaking" Research in Auto-Flowering PREMIUM MT Newswires ? last month ACB +10.71% Aurora Cannabis Advances "Groundbreaking" Research in Auto-Flowering Aurora Cannabis Advances "Groundbreaking" Research in Auto-Flowering PREMIUM MT Newswires ? last month ACB +10.71% Aurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Future Cultivation Excellence Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pioneering ground-breaking research in auto-flowering technology. Auto-flowering is a genetic characteristic that automatically transitions the plant from the vegetative stage to the flowering stage rather than relying on changes in light cycles. This innovative work provides foundational insight on flowering mechanism in cannabis, which will support future breeding strategies, and can b PR Newswire ? last month ACB +10.71% Aurora Cannabis and Vectura Fertin Pharma, Inc. announce launch of novel Luo CBD lozenge Aurora Cannabis Inc. ("Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canadian-based global medical cannabis company, and Vectura Fertin Pharma, Inc., an innovator in wellness and healthcare, are pleased to announce the launch of the newly developed Luo CBD lozenge. CNW Group ? last month ACB +10.71% NASDAQ Cannabis Titan, Aurora, Could Boost 31% Sales Surge With This New CBD Lozenge Partnership Aurora Cannabis Inc. (NASDAQ:ACB) has partnered with Vectura Fertin Pharma, Inc. to launch a CBD lozenge in the form of a dissolvable tablet that delivers the precise dose of cannabidiol (CBD). The new product is expected to enhance patient care by providing an alternative consumption method without psychoactive effects. The partnership leverages Aurora’s extensive medical cannabis patient platform, said Aurora CEO Miguel Martin, who added that the company intends to broaden Canadian healthcare Benzinga ? last month ACB +10.71% Prediction: Aurora Cannabis Will Be Worth More Than Canopy Growth in 5 Years While these stocks are both highly risky investments, Aurora Cannabis may be in a better position right now than its longtime rival. Motley Fool ? last month ACB +10.71% Aurora Cannabis Dominates 30% Of Canada's Medical Marijuana Exports: Will Its Bold International Expansion Pay Off? Aurora Cannabis (NASDAQ:ACB) saw its international sales for the first half of 2024 reach C$39.3 million ($28.9 million), reflecting a 31% year-over-year increase. This growth includes the full acquisition of MedReleaf Australia in February 2024, which contributed significantly to the sales boost. A Wednesday report by Pablo Zuanic of Zuanic & Associates provides a detailed analysis of the company’s recent activities and financial standing. International Sales And Market Position Aurora remains Benzinga ? last month ACB +10.71% Aurora Cannabis Had a Strong Q1, but Investors Should Expect a Slowdown in Future Quarters Tread carefully with this stock even if it might look like a safer buy these days. Motley Fool ? 2 months ago ACB +10.71% Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held Friday August 9, 2024 by virtual webcast. The total number of shares represented by shareholders present in person (virtually) and by proxy at the Meeting was 14,855,306, representing 27.23% of Aurora's issued and outstanding common shares as of CNW Group ? 2 months ago ACB +10.71% Aurora Cannabis First Quarter 2025 Earnings: Beats Expectations Aurora Cannabis ( TSE:ACB ) First Quarter 2025 Results Key Financial Results Revenue: CA$83.4m (up 11% from 1Q 2024... Simply Wall St. ? 2 months ago ACB +10.71% Update: Aurora Cannabis Jumps 7.5% After Swinging to a Fiscal Q1 Profit Update: Aurora Cannabis Jumps 7.5% After Swinging to a Fiscal Q1 Profit PREMIUM MT Newswires ? 2 months ago ACB +10.71% Aurora Cannabis (ACB) Q1 2025 Earnings Call Transcript ACB earnings call for the period ending June 30, 2024. Motley Fool ? 2 months ago ACB +10.71% Aurora Cannabis Inc. (ACB) Reports Q1 Loss, Tops Revenue Estimates Aurora Cannabis (ACB) delivered earnings and revenue surprises of 68.57% and 20.16%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? Zacks ? 2 months ago ACB +10.71% WRBY Performance Overview Trailing total returns as of 10/22/2024, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index Return ACB.TO S&P/TSX Composite index YTD +29.69% +17.93% 1-Year +38.20% +29.30% 3-Year -90.78% +16.52%
